RayzeBio, Inc. Common Stock
RYZB · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $129 | $51 | $144 |
| Short-Term Investments | $167 | $149 | $3 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $3 | $0 |
| Total Curr. Assets | $300 | $202 | $147 |
| Property Plant & Equip (Net) | $24 | $14 | $1 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 |
| Total NC Assets | $25 | $14 | $1 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $325 | $216 | $148 |
| Liabilities | – | – | – |
| Payables | $3 | $1 | $0 |
| Short-Term Debt | $1 | $2 | $1 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $3 | $1 |
| Total Curr. Liab. | $10 | $6 | $2 |
| LT Debt | $9 | $7 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $416 | $258 | $150 |
| Total NC Liab. | $426 | $265 | $150 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $11 | $9 | $1 |
| Total Liabilities | $436 | $271 | $151 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$130 | -$55 | -$7 |
| AOCI | -$1 | -$0 | -$0 |
| Other Equity | $19 | $1 | $4 |
| Total Equity | -$111 | -$55 | -$3 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $325 | $216 | $148 |
| Net Debt | -$119 | -$42 | -$143 |